PATENTSCOPE will be unavailable a few hours for maintenance reason on Monday 03.02.2020 at 10:00 AM CET
Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2004024182) METHOD FOR ISOLATING HEPATITIS C VIRUS PEPTIDES
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2004/024182 International Application No.: PCT/EP2003/009482
Publication Date: 25.03.2004 International Filing Date: 27.08.2003
Chapter 2 Demand Filed: 01.04.2004
IPC:
A61K 38/00 (2006.01) ,A61K 39/00 (2006.01) ,A61K 39/12 (2006.01) ,A61K 39/145 (2006.01) ,A61K 39/29 (2006.01) ,C07K 7/06 (2006.01) ,C07K 7/08 (2006.01) ,C07K 14/005 (2006.01) ,C07K 14/045 (2006.01) ,C07K 14/11 (2006.01) ,C07K 14/18 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
12
Viral antigens
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
12
Viral antigens
145
Orthomyxoviridae, e.g. influenza virus
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
12
Viral antigens
29
Hepatitis virus
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
7
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
04
Linear peptides containing only normal peptide links
06
having 5 to 11 amino acids
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
7
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
04
Linear peptides containing only normal peptide links
08
having 12 to 20 amino acids
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005
from viruses
01
DNA viruses
03
Herpetoviridae, e.g. pseudorabies virus
05
Epstein-Barr virus
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005
from viruses
01
DNA viruses
03
Herpetoviridae, e.g. pseudorabies virus
045
Cytomegalovirus
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005
from viruses
08
RNA viruses
11
Orthomyxoviridae, e.g. influenza virus
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005
from viruses
08
RNA viruses
18
Togaviridae, e.g. flavivirus, pestivirus, yellow fever virus, hepatitis C virus, japanese encephalitis virus
Applicants:
INTERCELL AG [AT/AT]; Campus Vienna Biocenter 6 A-1030 Vienna, AT (AllExceptUS)
BUSCHLE, Michael [DE/AT]; AT (UsOnly)
HABEL, Andre [DE/AT]; AT (UsOnly)
KLADE, Christoph [AT/AT]; AT (UsOnly)
MATTNER, Frank [DE/AT]; AT (UsOnly)
OTAVA, Oleksandr [UA/AT]; AT (UsOnly)
VYTVYTSKA, Oresta [UA/AT]; AT (UsOnly)
ZAUNER, Wolfgang [AT/AT]; AT (UsOnly)
ZINKE, Sandra [AT/AT]; AT (UsOnly)
KIRLAPPOS, Helen [AT/AT]; AT (UsOnly)
Inventors:
BUSCHLE, Michael; AT
HABEL, Andre; AT
KLADE, Christoph; AT
MATTNER, Frank; AT
OTAVA, Oleksandr; AT
VYTVYTSKA, Oresta; AT
ZAUNER, Wolfgang; AT
ZINKE, Sandra; AT
KIRLAPPOS, Helen; AT
Agent:
SONN & PARTNER; Riemergasse 14 A-1010 Vienna, AT
Priority Data:
03450171.811.07.2003EP
A 1376/200213.09.2002AT
PCT/EP03/0200527.02.2003EP
Title (EN) METHOD FOR ISOLATING HEPATITIS C VIRUS PEPTIDES
(FR) PROCEDE POUR ISOLER DES PEPTIDES DU VIRUS DE L'HEPATITE C
Abstract:
(EN) Described is a method for isolating Hepatitis C Virus peptides (HPs) which have a binding capacity to a MHC/HLA molecule or a complex comprising said HCV-peptide and said MHC/HLA molecule characterized by the following steps: - providing a pool of HCV-peptide, said pool containing HCV-peptides which bind to said MHC/HLA molecule and HCV-peptides which do not bind to said MHC/HLA molecule, -contacting said MHC/HLA molecule with said pool of HCV-peptides whereby a HCV-peptide which has a binding capacity to said MHC/HLA molecule binds to said MHC/HLA molecule and a complex comprising said HCV-peptide and said MHC/HLA molecule is formed, -detecting and optionally separating said complex from the HCV-peptide which do not bind to said MHC/HLA molecule and optionally isolating and characterising the HCV-peptide from said complex.
(FR) La présente invention concerne un procédé pour isoler des peptides du virus de l'hépatite C (HPs) qui ont une capacité de liaison à une molécule CMH/HLA ou un complexe comprenant ledit peptide du virus de l'hépatite C (VHC) et ladite molécule CMH/HLA. Le procédé se caractérise en ce qu'il comprend les étapes suivantes: mise à disposition d'un ensemble de peptides de VHC, ledit ensemble contenant des peptides de VHC qui se lient à ladite molécule CMH/HLA et des peptides de VHC qui ne se lient pas à ladite molécule CMH/HLA; mise en contact de ladite molécule CMH/HLA avec ledit ensemble de peptides de VHC, un peptide de VHC qui a une capacité de liaison à ladite molécule CMH/HLA se liant alors à ladite molécule CMH/HLA et un complexe comprenant ledit peptide de VHC et la molécule CMH/HLA étant formé; détection et éventuellement séparation dudit complexe du peptide de VHC qui ne se lie pas à ladite molécule de CMH/HLA et éventuellement isolation et caractérisation du peptide de VHC dudit complexe.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP1537418JP2006504687EP2402026US20060216691US20090081246CN1695060
CA2484339AU2003258672